In the non-canonical NF-κB pathway, binding of the initiating kinase NIK to the pathway's target, p100, serves a nonenzymatic "licensing" role

The non-canonical NF-κB pathway plays pivotal roles in adaptive immunity. It is initiated by NIK-mediated phosphorylation of IKK1, which phosphorylates p100 and promotes processing of newly synthesized p100. However, IKK1 can also be activated by other kinases to mediate distinct functions. Why IKK1-induced p100 processing occurs efficiently downstream of NIK but not of other kinases is unknown. Here, we show that whereas pre-existing p100 can be phosphorylated by IKK1 without NIK, phosphorylation of newly synthesized p100 critically depends on additional non-enzymatic functions of NIK's C-terminal portion. NIK binds IKK1 and restrains its kinase activity, while its binding to p100 enhances p100 phosphorylation. Single-molecule FRET spectroscopy and XL-MS revealed that the C-terminal region of p100 adopts a folded-back conformation and undergoes structural rearrangement upon NIK binding, likely accounting for this enhancement. Thus, NIK not only initiates the pathway but also dictates its specificity through binding to its downstream substrate.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-18
DOI
https://doi.org/10.64898/2026.11.16.766979
Primary Topic
NF-κB Signaling Pathways
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

In the non-canonical NF-κB pathway, binding of the initiating kinase NIK to the pathway's target, p100, serves a nonenzymatic "licensing" role

Gilad Haran, Dana Reichmann, Moshe Goldsmith, David Scheerer et al.
1 links
bioRxiv (Cold Spring Harbor Laboratory)
NF-κB Signaling Pathways
preprint

In the non-canonical NF-κB pathway, binding of the initiating kinase NIK to the pathway's target, p100, serves a nonenzymatic "licensing" role

Gilad Haran, Dana Reichmann, Moshe Goldsmith, David Scheerer, Tianzhen Wang, David Wallach, Xun Liang, David Morgenstern, Konstantin Bogdanov, Chaitanyakumar Amballa, Mike Gardarsky
preprint en

Abstract

The non-canonical NF-κB pathway plays pivotal roles in adaptive immunity. It is initiated by NIK-mediated phosphorylation of IKK1, which phosphorylates p100 and promotes processing of newly synthesized p100. However, IKK1 can also be activated by other kinases to mediate distinct functions. Why IKK1-induced p100 processing occurs efficiently downstream of NIK but not of other kinases is unknown. Here, we show that whereas pre-existing p100 can be phosphorylated by IKK1 without NIK, phosphorylation of newly synthesized p100 critically depends on additional non-enzymatic functions of NIK's C-terminal portion. NIK binds IKK1 and restrains its kinase activity, while its binding to p100 enhances p100 phosphorylation. Single-molecule FRET spectroscopy and XL-MS revealed that the C-terminal region of p100 adopts a folded-back conformation and undergoes structural rearrangement upon NIK binding, likely accounting for this enhancement. Thus, NIK not only initiates the pathway but also dictates its specificity through binding to its downstream substrate.

bioRxiv (Cold Spring Harbor Laboratory)
Hebrew University of Jerusalem (IL), Weizmann Institute of Science (IL)
NF-κB Signaling Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon